The European Medicines Agency points out that the withdrawal of batches of influenza vaccines, produced by Novartis, was decided as a precautionary measure. The presence of impurities was observed on certain batches, leading France, Italy, Germany, Switzerland and Austria to withdraw them from sale. A press release from the Ministry of Health specifies that at this stage “no impurity was found in France and no pharmacovigilance escalation was noted. There is currently no known indication of danger for patients. having used this mark on the national territory “. A procedure is underway to find out whether the lots should be definitively withdrawn from the market.
.
